Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HRH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | SLC30A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | CNTRL | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | ZDHHC8 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
mRNA | ZBED3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | KIAA0101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | RBMX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | DCDC1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | FAM43B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | RELB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |